Does BRODALUMAB Cause Lung neoplasm malignant? 7 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Lung neoplasm malignant have been filed in association with BRODALUMAB (Siliq). This represents 0.3% of all adverse event reports for BRODALUMAB.
7
Reports of Lung neoplasm malignant with BRODALUMAB
0.3%
of all BRODALUMAB reports
2
Deaths
4
Hospitalizations
How Dangerous Is Lung neoplasm malignant From BRODALUMAB?
Of the 7 reports, 2 (28.6%) resulted in death, 4 (57.1%) required hospitalization, and 2 (28.6%) were considered life-threatening.
Is Lung neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BRODALUMAB. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does BRODALUMAB Cause?
Psoriasis (418)
Drug ineffective (177)
Arthralgia (175)
Fatigue (152)
Psoriatic arthropathy (141)
Intentional product use issue (136)
Headache (126)
Therapy interrupted (126)
Product dose omission issue (124)
Disease recurrence (118)
What Other Drugs Cause Lung neoplasm malignant?
RANITIDINE (15,214)
ADALIMUMAB (698)
TIOTROPIUM (637)
ETANERCEPT (612)
METHOTREXATE (522)
CLOZAPINE (440)
APIXABAN (411)
ALBUTEROL (403)
INFLIXIMAB (379)
BUDESONIDE\FORMOTEROL (353)
Which BRODALUMAB Alternatives Have Lower Lung neoplasm malignant Risk?
BRODALUMAB vs BROLUCIZUMAB
BRODALUMAB vs BROLUCIZUMAB-DBLL
BRODALUMAB vs BROMAZEPAM
BRODALUMAB vs BROMFENAC
BRODALUMAB vs BROMHEXINE